Literature DB >> 26495795

Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review.

Mia Schmidt-Hansen1, Sabine Berendse, William Hamilton.   

Abstract

OBJECTIVES: The aim of this study was to quantify the risk of pancreatic cancer in patients presenting in primary care with symptoms that may indicate pancreatic cancer.
METHODS: We searched MEDLINE, PreMEDLINE, EMBASE, the Cochrane Library, Web of Science, and ISI Proceedings (1980 to August 2014) and PsychINFO (1980 to May 2013) for diagnostic studies of symptomatic adult patients in primary care. Study quality was assessed using QUADAS-II, and data were extracted to calculate the positive predictive values (PPVs) of symptoms, singly or in combination, for pancreatic cancer.
RESULTS: Eight studies with 3,438,363 patients were included. The PPV of jaundice was more than 4.1% in patients 40 years or older and increased with age, although only 30% of patients reported jaundice. The PPVs of other single symptoms were low, with the highest PPV being 1% for repeated attendance with abdominal pain in patients 60 years or older. Excluding jaundice, symptom combinations with high PPVs were those including weight loss, ranging from 1.5% to 2.7% in patients 60 years or older, apart from when weight loss was combined with malaise (PPV, 0.9%).
CONCLUSION: The only high-risk feature of pancreatic cancer in primary care was jaundice, and this clearly warrants investigation. Weight loss accompanied by a second symptom may warrant investigation, although this would probably require abdominal computed tomography.

Entities:  

Mesh:

Year:  2016        PMID: 26495795     DOI: 10.1097/MPA.0000000000000527

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  11 in total

1.  Online information analysis on pancreatic cancer in Korea using structural topic model.

Authors:  Minji Seo; Nayoung Lee; Junli Park; Wonkwang Jo; Yeol Kim
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

Review 2.  Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review.

Authors:  Marlies Vornhülz; Sofia Anton; Balint Eross; Zsolt Szakács; Peter Hegyi; Ivonne Regel; Claus Belka; Maximilian Niyazi; Julia Mayerle; Georg Beyer
Journal:  Radiat Oncol       Date:  2022-06-17       Impact factor: 4.309

3.  Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis.

Authors:  Brian D Nicholson; William Hamilton; Jack O'Sullivan; Paul Aveyard; Fd Richard Hobbs
Journal:  Br J Gen Pract       Date:  2018-04-09       Impact factor: 5.386

4.  Tumour Markers in the Differential Diagnosis of Patients With Isolated Involuntary Weight Loss.

Authors:  Jaume Trape; Jordi Aligue; Mireia Vicente; Anna Arnau; Antonio San-Jose; Josep Ordeig; Roser Ordeig; Mariona Bonet; Andres Abril; Omar El-Boutrouki; Carolina Gonzalez-Fernandez; Maria Sala; Cristina Figols; Elisabeth Gonzalez-Garcia; Lourdes Montsant; Domingo Ruiz
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

5.  Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.

Authors:  Ariadna Martín-Blázquez; Cristina Jiménez-Luna; Caridad Díaz; Joaquina Martínez-Galán; Jose Prados; Francisca Vicente; Consolación Melguizo; Olga Genilloud; José Pérez Del Palacio; Octavio Caba
Journal:  Cancers (Basel)       Date:  2020-04-18       Impact factor: 6.639

6.  Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.

Authors:  Mahdi Sheikh; Sahar Masoudi; Razieh Bakhshandeh; Alireza Moayyedkazemi; Farhad Zamani; Sepideh Nikfam; Masoumeh Mansouri; Neda Ghamarzad Shishavan; Saman Nikeghbalian; Paul Brennan; Reza Malekzadeh; Akram Pourshams
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

7.  CircRNF13 Promotes the Malignant Progression of Pancreatic Cancer through Targeting miR-139-5p/IGF1R Axis.

Authors:  Xinyuan Liu; Lei Zhou; Yankun Chen; Xueyi Jiang; Jianxin Jiang
Journal:  J Oncol       Date:  2021-12-03       Impact factor: 4.375

8.  Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases.

Authors:  Yuxin Shen; Xiaofei Zhu; Fei Cao; Hongliang Xie; Xiaoping Ju; Yangsen Cao; Shuiwang Qing; Zhen Jia; Lei Gu; Fang Fang; Huojun Zhang
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

9.  Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel.

Authors:  Samuli I Nissinen; Markus Venäläinen; Pekka Kumpulainen; Antti Roine; Merja R Häkkinen; Jouko Vepsäläinen; Niku Oksala; Tuomo Rantanen
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

10.  Pre-diagnostic delays caused by gastrointestinal investigations do not affect outcomes in pancreatic cancer.

Authors:  Jeyakumar R Apollos; Sharukh Sami; Manju Nadh Prasanth; Jerusha Jeyakumar; Angus K McFadyen
Journal:  Ann Med Surg (Lond)       Date:  2018-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.